SI-B-029A

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSI-B-029A

Drug Alias NameSI-B-029A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSystImmune

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSystImmune

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsColonic Neoplasms

Other Information

ATC CodeN/A